Dash Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-26.
Dash Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 26, 2025. The filing reports $11M sold. Its industry group is Biotechnology. It names DAVID JOHNSON (Executive Officer, Director), ALEXANDER TALLETT (Executive Officer, Director) (SEC Form D, June 26, 2025).
In its own words: “A modern, automated platform engineered from the ground up to deliver high-quality and dramatically accelerated bioanalysis.” (dash.bio, checked November 1, 2026)
Is this your company?
Sell to companies like Dash Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Dash Bio, Inc.
Free to see. No signup.
More on the people and the money behind Dash Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in June 2025, largest first.
Get an email when Dash Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Dash Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Dash Bio, Inc. →Get the full cited report on Dash Bio, Inc.
What the filing shows about Dash Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Dash Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Dash Bio, Inc.'s address as 56 Broad Street, Ste 14011, Boston, MA 02109.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Dash Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Dash Bio, Inc. is a registered filer with the SEC (CIK 2041370) and has filed since 2024-10-17. 3 filings are on record, the latest on 2026-07-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Dash Bio, Inc.'s Form D of 2025-06-26 names DAVID JOHNSON and ALEXANDER TALLETT as its officers, directors or promoters.
Its new offerings report $47.12M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
David Johnson is named as Executive Officer and Director on the Form D that Dash Bio, Inc. filed with the SEC on 26 June 2025, one of 2 people that filing names.
Alexander Tallett is named as Executive Officer and Director on the Form D that Dash Bio, Inc. filed with the SEC on 26 June 2025, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2025-06-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Dash Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Dash Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dash Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Dash Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Dash Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Dash Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/dash-bio-inc-form-d-25000001